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Sir,
Choudhury has shown, at the mRNA level using QPCR, that
heterogeneous nuclear ribonucleoprotein k (hnRNP K) is over-
expressed in oral squamous cell carcinoma. We identified hnRNP
K as being upregulated in a different cancer, namely colorectal
(Carpenter et al, 2006a), which strengthens the rationale that
hnRNP K is important for tumorigenesis. Interestingly, using a
tissue microarray with matching clinicopathological parameters,
hnRNP K was described as being localised exclusively in the
nucleus of normal colon cells whereas in colorectal tissues the
protein was present in both the cytoplasmic and nuclear
compartments (Carpenter et al, 2006b). The dysregulation of
hnRNP K cellular localisation in colon cancer is suggestive that the
protein has an altered cellular function, which is not surprising, as
the protein has several cellular roles including, transcription,
translation, mRNA shuttling and RNA editing.
As a result of matching clinicopathological data, our colon
cancer study also revealed that hnRNP K protein expression
increased as Dukes staging progressed and in Dukes C patients,
high nuclear expression of hnRNP K was associated with good
prognosis. As suggested by Choudhury, it will be interesting to
determine if disease progression and prognosis correlates with
hnRNP K protein expression in oral squamous carcinoma, as is the
case for colorectal cancer. It will also be beneficial to expand these
observations to different cancer types.
Overall, hnRNP K continues to emerge as an interesting protein,
which through both mechanistic studies and expression profiling
in different cancer types, has strongly been implicated as a key
player of tumorigenesis. Validation through independent studies
provides a strong portfolio of evidence that suggests hnRNP K is a
good target for anticancer therapeutic and also holds the potential
to be used as a diagnostic or prognostic marker.
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